ChiCTR2000029357 版本V1.0 版本创建时间2020/01/26 06:59:40 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000029357 

最近更新日期:

Date of Last Refreshed on:

2020-01-26 05:30:43 

注册时间:

Date of Registration:

2020-01-25 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

靳三针对自闭症谱系障碍儿童社交与情绪障碍的正向调节及脑-肠轴机制研究

Public title:

Positive Regulation of the Social and Emotional Disorders and Brain-Gut Axis Mechanisms for Children with Autism Spectrum Disorders by Jin's 3 needle Technique

注册题目简写:

English Acronym:

研究课题的正式科学名称:

靳三针对自闭症谱系障碍儿童社交与情绪障碍的正向调节及脑-肠轴机制研究

Scientific title:

Positive Regulation of the Social and Emotional Disorders and Brain-Gut Axis Mechanisms for Children with Autism Spectrum Disorders by Jin's 3 needle Technique

研究课题代号(代码):

Study subject ID:

908304669175

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

袁青 

研究负责人:

袁青 

Applicant:

Yuan Qing 

Study leader:

Yuan Qing 

申请注册联系人电话:

Applicant telephone:

+86 13902211008

研究负责人电话:

Study leader's telephone:

+86 13902211008

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yuanqing1005@126.com

研究负责人电子邮件:

Study leader's E-mail:

yuanqing1005@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省广州市白云区机场路12号

研究负责人通讯地址:

广东省广州市白云区机场路12号

Applicant address:

12 Jichang Road, Baiyun District, Guangzhou, Guangdong, China

Study leader's address:

12 Jichang Road, Baiyun District, Guangzhou, Guangdong, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

广州中医药大学

Applicant's institution:

Guangzhou University of Chinese Medcine

研究负责人所在单位:

广州中医药大学

Affiliation of the Leader:

Guangzhou University of Chinese Medcine

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

NO.ZYYECK[2019]110

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

广州中医药大学第一附属医院伦理委员会

Name of the ethic committee:

Ethical review boards of First Affiliated Hospital of Guangzhou University of Chinese Medcine

伦理委员会批准日期:

Date of approved by ethic committee:

2019-09-16 00:00:00

伦理委员会联系人:

黎欣盈

Contact Name of the ethic committee:

Li Xinying

伦理委员会联系地址:

广东省广州市白云区机场路16号

Contact Address of the ethic committee:

16 Jichang Road, Baiyun District, Guangzhou, Guangdong, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 020-36588667

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

广州中医药大学

Primary sponsor:

Guangzhou University of Chinese Medcine

研究实施负责(组长)单位地址:

广东省广州市白云区机场路12号

Primary sponsor's address:

12 Jichang Road, Baiyun District, Guangzhou, Guangdong, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东省

市(区县):

Country:

China

Province:

Guangdong

City:

单位(医院):

广州中医药大学

具体地址:

广东省广州市白云区机场路12号

Institution
hospital:

Guangzhou University of Chinese Medcine

Address:

12 Jichang Road, Baiyun District, Guangzhou

经费或物资来源:

广东省重点领域研发计划项目

Source(s) of funding:

Guangdong Province Key Area R & D Plan Project

Target disease:

Autism

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本课题设计开展多中心、大样本RCT临床研究,在靳三针治疗儿童自闭症总体改善的基础上,重点观察其社交与情绪、行为、认知能力的改变;胃肠功能变化(包括排便能力、肠道菌群、胃肠动力等),进行统计学分析。阐明靳三针能通过改善自闭症患儿胃肠功能从而影响其脑发育,最终产生对其社交与情绪障碍的正向调节作用,进一步验证靳三针可通过从胃肠论治的脑-肠轴法有效治疗自闭症的依据。  

Objectives of Study:

This project is designed to conduct a multi-center, large-sample RCT clinical study. Based on the overall improvement of children with autism treated by Jin Sanpin, the focus is on changes in social and emotional, behavioral, and cognitive abilities; changes in gastrointestinal function (including defecation) Ability, intestinal flora, gastrointestinal motility, etc.) for statistical analysis. To clarify that Jin San Acupuncture can affect the brain development of children with autism by improving gastrointestinal function, and finally produce a positive regulating effect on their social and emotional disorders, further verifying that Jin San Acupuncture can treat brain from gastrointestinal- Basis of intestinal axis method for effective treatment of autism.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)符合上述中西医诊断标准;
(2)年龄在 2-12 岁以内;
(3)自愿加入本试验并能坚持针刺、行为干预疗法 12 个月;
(4)观察期内未采取除针灸和行为干预疗法外的其他治疗方法;
(5)对本研究有正确而客观的认识,有良好的依从性;
(6)愿意参加本次研究的知情同意者(需签定知情同意书);

Inclusion criteria

(1) Comply with the above-mentioned diagnostic standards of Chinese and Western medicine;
(2) Aged 2 to 12 years;
(3) Voluntarily participate in this trial and can adhere to acupuncture and behavioral intervention therapy for 12 months;
(4) During the observation period, no other treatment methods except acupuncture and behavior intervention therapy were adopted;
(5) Have a correct and objective understanding of this research and have good compliance;
(6) Informed consent willing to participate in this research (requires signed informed consent).

排除标准:

(1)3 个月内接受过针刺治疗者;
(2)合并有严重心脑血管、肝、肾、血液等系统疾病者;
(3)同时患有 Asperger(阿斯伯格)综合征、heller 综合征(儿童瓦解性精神病、又称婴儿痴呆)、Retts(烈特士)综合征、特定感受性语言障碍或儿童精神分裂症;
(4)有严重出血性疾病倾向者。

Exclusion criteria:

(1) Those who have received acupuncture treatment within 3 months;
(2) Patients with severe cardiovascular, cerebrovascular, liver, kidney, blood and other system diseases;
(3) Suffering from both Asperger syndrome and Heller syndrome (children's tile)Psychosis (also known as infantile dementia), Retts syndrome, specific susceptibility Speech impairment or child schizophrenia;
(4) Those with a tendency to severe bleeding disorders.

研究实施时间:

Study execute time:

From 2020-01-01 00:00:00 To 2023-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-06-01 00:00:00 To 2022-12-31 00:00:00  

干预措施:

Interventions:

组别:

靳三针治疗A组

样本量:

138

Group:

Jin'3 needle technique treatment group A (with no gastrointestinal 3-needle)

Sample size:

干预措施:

靳三针疗法(不包括胃肠三针)

干预措施代码:

Intervention:

Jin'3-needle therapy(Excluding gastrointestinal 3-needle)

Intervention code:

组别:

靳三针治疗B组

样本量:

138

Group:

Jin'3 needle technique treatment group A (with gastrointestinal 3-needle)

Sample size:

干预措施:

靳三针疗法(包括胃肠三针)

干预措施代码:

Intervention:

Jin'3-needle therapy(incluing gastrointestinal 3-needle)

Intervention code:

组别:

胃肠三针组

样本量:

138

Group:

gastrointestinal 3-needle

Sample size:

干预措施:

胃肠三针

干预措施代码:

Intervention:

gastrointestinal 3-needle

Intervention code:

组别:

对照组

样本量:

138

Group:

Control

Sample size:

干预措施:

常规康复训练疗法

干预措施代码:

Intervention:

Conventional rehabilitation training therapy

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东省 

市(区县):

 

Country:

China 

Province:

Guangdong 

City:

 

单位(医院):

广州中医药大学第一附属医院 

单位级别:

三甲医院 

Institution
hospital:

16 Jichang Road, Baiyun District ,Guangzhou, Guangdong, China

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

重庆市 

市(区县):

 

Country:

China 

Province:

Chongqing 

City:

 

单位(医院):

中国人民解放军陆军军医大学第二附属医院 

单位级别:

三甲医院 

Institution
hospital:

The Second Affiliated Hospital of PLA Military Medical University

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

广东省 

市(区县):

 

Country:

China 

Province:

Guangdong 

City:

 

单位(医院):

广东省妇幼保健院 

单位级别:

三甲医院 

Institution
hospital:

Maternal and Child Health Hospital of Guangdong Province

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

广东省 

市(区县):

 

Country:

China 

Province:

Guangdog 

City:

 

单位(医院):

广州市越秀区儿童医院 

单位级别:

三甲医院 

Institution
hospital:

Children's Hospital of Yuexiu District, Guangzhou

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

海南省 

市(区县):

 

Country:

China 

Province:

Hai'nan 

City:

 

单位(医院):

海南医学院 

单位级别:

大学 

Institution
hospital:

Hainan Medical College

Level of the institution:

University

国家:

中国

省(直辖市):

广东省 

市(区县):

 

Country:

China 

Province:

Guangdong 

City:

 

单位(医院):

广州白云区袁青中医诊所 

单位级别:

 

Institution
hospital:

Yuanqing Traditional Chinese Medicine Clinic, Baiyun District, Guangzhou

Level of the institution:

测量指标:

Outcomes:

指标中文名:

社交与情绪障碍评定

指标类型:

主要指标

Outcome:

Social and emotional disorders assessment

Type:

Primary indicator

测量时间点:

治疗 1 周、2 周、3 周、4 周、6 周、8 周、12 周和治疗后 6 个月

测量方法:

自闭症诊断观察 量(ADOS)和 Conners 调查问卷

Measure time point of outcome:

Measure method:

ADOS and Conners questionnaire

指标中文名:

行为能力评定

指标类型:

主要指标

Outcome:

Performance assessment

Type:

Primary indicator

测量时间点:

治疗 1 周、2 周、3 周、4 周、6 周、8 周、12 周和治疗后 6 个月

测量方法:

儿童孤独症评定量表 (CARS)、儿童自闭症行为量表(Autism Behavior Checklist,ABC)

Measure time point of outcome:

Measure method:

CARS, Autism Behavior Checklist questionnaires

指标中文名:

认知能力评定

指标类型:

主要指标

Outcome:

Cognitive ability assessment

Type:

Primary indicator

测量时间点:

治疗 1 周、2 周、3 周、4 周、6 周、8 周、12 周和治疗后 6 个月

测量方法:

贝利婴幼儿发育量表(BSID) 和韦氏儿童智力量表(WISC)

Measure time point of outcome:

Measure method:

BSID, WISC questionnaires

指标中文名:

胃肠功能评分

指标类型:

主要指标

Outcome:

Gastrointestinal Function Score

Type:

Primary indicator

测量时间点:

治疗 1 周、2 周、3 周、4 周、6 周、8 周、12 周和治疗后 6 个月

测量方法:

Wexner 评分表

Measure time point of outcome:

Measure method:

Wexner score

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

粪便

组织:

Sample Name:

excrement

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

尿液

组织:

Sample Name:

Urine

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 2 years
最大 Max age 12 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由除针灸治疗以外的课题组第三方专门人员负责,运用统计学软件随机数字表后信封法隐匿

Randomization Procedure (please state who generates the random number sequence and by what method):

Those who are not doing acupuncture use random number table named the Envelope Method.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Open label

Blinding:

Open label

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

试验结束后在数据共享平台ResMan实现共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Raw data will be shared with the public on Public data platform (ResMan) within 6 month after the trial is finished

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

ResMan数据管理平台

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

ResMan research manager

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2020-01-26 05:30:43